Vitamin D Council needs your help...

Tax-deductible!

Together we can end the illness and disease caused by the worldwide epidemic of vitamin D deficiency.

About Vitamin D Council

Contact Vitamin D Council

Sponsor Vitamin D Council

Follow us on:

Vitamin D Products

(off-site)

These companies donate to the Vitamin D Council.

D-Lite, Renew, & SunSplash UV/Tanning Systems
In-Home ZRT Vitamin D Blood Test Kit
Get Premium Quality Vitamin D Supplements at Great Prices
Vitamin D3 Plus™ from Bio-Tech — contains the cofactors Vitamin D needs to work properly.

Vitamin D Research

back to research menu

Heart Disease

High prevalence of vitamin D deficiency and its association with left ventricular dilation: An echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis. 2010 Apr 14.
Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res. 2010 Mar 29.
Vitamin D deficiency and cardiovascular disease: Is there a role for vitamin D therapy in heart failure? Curr Opin Investig Drugs. 2010 Mar;11(3):309–14.
Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention. Expert Opin Ther Targets. 2010 Mar;14(3):243–51.
Vitamin D and cardiovascular risk. Int Urol Nephrol. 2010 Mar;42(1):165–71.
Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother. 2010 Feb;8(1):4–33.
Maternal vitamin D deficiency leads to cardiac hypertrophy in rat offspring. Reprod Sci. 2010 Feb;17(2):168–76.
Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med. 2010 Jan–Feb;8(1):11–8.
Sun, vitamin D, and cardiovascular disease. J Photochem Photobiol B. 2010 Jan 22.
Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). Am J Cardiol. 2010 Jan 1;105(1):122–8.
Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2010 Jan;59(1):242–8.
Macular degeneration, heart disease, and vitamin d. Ophthalmology. 2010 Jan;117(1):194.
Vitamin D receptor (VDR) polymorphisms in the cardiac variant of Gaucher disease. Pediatr Cardiol. 2010 Jan;31(1):30–2.
Vitamin D, cardiovascular disease and mortality in patients with kidney disease. Ugeskr Laeger. 2009 Dec 7;171(50):3684–9. Review.
A new role for vitamin D receptor activation in chronic kidney disease. Am J Physiol Renal Physiol. 2009 Dec;297(6):F1502–9. Review.
Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis. 2009 Dec;207(2):585–90.
Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension. Pharmacogenomics. 2009 Nov;10(11):1789–97.
Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat. Nutr Metab Cardiovasc Dis. 2009 Oct 14.
No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population. DNA Cell Biol. 2009 Oct;28(10):521–5.
Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden. Arch Gerontol Geriatr. 2009 Sep–Oct;49(2):250–4.
Fibroblast growth factor 23 and the future of phosphorus management. Curr Opin Nephrol Hypertens. 2009 Sep 16.
Calcium supplementation, cardiovascular disease and mortality in older women. Pharmacoepidemiol Drug Saf. 2009 Sep 15.
Vitamin D supplements vs plasma level. Arch Intern Med. 2009 Sep 14;169(16):1536; author reply 1536–7.
Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009 Sep;4(9):1515–22. Review.
Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med. 2009 Sep;122(9):793–802. Review.
Vitamin D deficiency and mortality. Curr Opin Clin Nutr Metab Care. 2009 Aug 25.
Peripartum cardiomyopathy in an obese pregnant woman. Ugeskr Laeger. 2009 Aug 24;171(35):2487–9.
Calcium and Vitamin D Status in Heart Failure Patients in Isfahan, Iran. Biol Trace Elem Res. 2009 Aug 19.
Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004. Pediatrics. 2009 Aug 3.
Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population. Pediatrics. 2009 Aug 3.
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009 Aug;20(8):1805–12.
Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults. Am J Ther. 2009 Jul–Aug;16(4):326–32.
The role of vitamin D in the development of cardiac failure. Orv Hetil. 2009 Jul 26;150(30):1397–402.
Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009 Jul;338(1):40–4.
Vitamin d and cardiovascular disease. Curr Vasc Pharmacol. 2009 Jul;7(3):414–22.
Differences in vitamin D levels likely explain ethnic differences in incidence of congestive heart failure. Arch Intern Med. 2009 Jun 8;169(11):1075.
Circulating calcitriol concentrations and total mortality. Clin Chem. 2009 Jun;55(6):1163–70.
Vitamin D and cardiovascular disease. Pharmacotherapy. 2009 Jun;29(6):691–708.
Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Med Hypotheses. 2009 Jun;72(6):647–51.
Vitamin D deficiency and myocardial dysfunction. J Am Coll Cardiol. 2009 May 26;53(21):2011; author reply 2012–3.
Effect of a Combined Therapeutic Approach of Intensive Lipid Management, Omega-3 Fatty Acid Supplementation, and Increased Serum 25 (OH) Vitamin D on Coronary Calcium Scores in Asymptomatic Adults. Am J Ther. 2009 May 19.
Vitamin D Deficiency and Its Correlations With Increased Cardiovascular Incidences. Am J Ther. 2009 May 15.
Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab. 2009 May;94(5):1483–90.
Methodology and baseline characteristics for the Sarcopenia and Hip Fracture study: a 5-year prospective study. J Gerontol A Biol Sci Med Sci. 2009 May;64(5):568–74.
Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2009 May;64(5):559–67.
Consequences of a plant-based diet with low dairy consumption on intake of bone-relevant nutrients. J Womens Health (Larchmt). 2009 May;18(5):691–8.
Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias? Med Hypotheses. 2009 May;72(5):581–3.
Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension. Open Respir Med J. 2009 Apr 14;3:53–60.
Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ Res. 2009 Apr 10;104(7):851–9.
Circulating Calcitriol Concentrations and Total Mortality. Clin Chem. 2009 Apr 9.
Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog Biophys Mol Biol. 2009 Mar 3.
Reduced relative lymphocyte count in african-americans with decompensated heart failure. Am J Med Sci. 2009 Mar;337(3):156—60.
Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish. Calcif Tissue Int. 2009 Mar;84(3):195–202.
Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res. 2009 Feb 15;81(3):500–8. Review.
Some new food for thought: the role of vitamin D in the mental health of older adults. Curr Psychiatry Rep. 2009 Feb;11(1):12–9.
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant. 2009 Feb;24(2):611–8.
Rheumatic manifestations of renal disease. Curr Opin Rheumatol. 2009 Jan;21(1):55–61. Review.
Vitamin D and the vasculature: can we teach an old drug new tricks? Expert Opin Ther Targets. 2009 Jan;13(1):29–38.
Vitamin D: skeletal and extra skeletal effects; recommendations for good practice. Presse Med. 2009 Jan;38(1):43–54. Review in French.
Vitamin D: current status and perspectives. Clin Chem Lab Med. 2008 Dec 22.
Effect of a Combined Therapeutic Approach of Intensive Lipid Management, Omega-3 Fatty Acid Supplementation, and Increased Serum 25 (OH) Vitamin D on Coronary Calcium Scores in Asymptomatic Adults. Am J Ther. 2008 Dec 15.
Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr. 2008 Dec;88(6):1469–77.
Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension. 2008 Dec;52(6):1106–12.
A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet. Eur J Endocrinol. 2008 Dec;159 Suppl 1:S101–5.
The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Mol Aspects Med. 2008 Dec;29(6):361–8. Review.
Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes. 2008 Dec;15(6):489–94. Review.
Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol (Paris). 2008 Dec;69(6):501–10. In French.
Adequate level of vitamin D is essential for maintaining good health. Postepy Hig Med Dosw (Online). 2008 Oct 9;62:502–10. In Polish.
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008 Oct;29(6):726–76. Review.
Vitamin D and Sunlight: Strategies for Cancer Prevention and Other Health Benefits. Clin J Am Soc Nephrol. 2008 Sep;3(5):1548–54.
Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: Interactions with endothelial function and thioredoxin-interacting protein. Eur J Pharmacol. 2008 Aug 20;590(1–3):290–6.
25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008 Aug 11;168(15):1629–37.
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol. 2008 Aug;19(8):1509–19.
Vitamin D and anti-aging medicine. Clin Calcium. 2008 Jul;18(7):980–5. Review in Japanese.
The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens. 2008 Jul;17(4):408–15. Review.
Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul;3(4):1144–51.
Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84. Review in Japanese.
Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 2008 Mar;127(3):229–38. Review.
Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis). Nefrologia. 2008;28 Suppl 3:67–78. In Spanish.
Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007 Sep 10;167(16):1730–7. Review.
25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007 Jul;50(1):69–77.
Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci. 2007 Summer;37(3):222–32.
Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States. Arch Intern Med. 2007 Jun 11;167:1159–1165.
25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men. Arch Intern Med. 2008 Jun 9;168(11):1174–1180.
Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84. Review in Japanese.
Incident solar radiation and coronary heart disease mortality rates in Europe. Eur J Epidemiol. 2008;23(9):609–14.
Hypocalcemia as a Cause of Reversible Cardiomyopathy with Ventricular Tachycardia. Ann Intern Med. 3 April 2007 | Volume 146 Issue 7 | Pages 541–542.
Effects of atorvastatin on vitamin d levels in patients with acute ischemic heart disease. Am J Cardiol. 2007 Apr 1;99(7):903–5.
Vitamin D supplementation and cardiovascular disease risk. Circulation. 2007 Feb 20;115(7):827–8. Editorial.
Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007 Feb 20;115(7):846–54.
Vitamin D and vascular calcification. Curr Opin Lipidol. 2007 Feb;18(1):41–6. Review.
Nutritional vitamin D deficiency presenting as hemichorea. J Child Neurol. 2007 Jan;22(1):74–6.
Effects of the Phytoestrogen Genistein on Some Predictors of Cardiovascular Risk in Osteopenic, Postmenopausal Women: A Two-Year Randomized, Double-Blind, Placebo-Controlled Study. J Clin Endocrinol Metab. 2007 Vol. 92, No. 8 3068–3075.
Relationships between Myocardial Injury, All-cause Mortality, Vitamin D, PTH, and Biochemical Bone Turnover Markers in Older Patients with Hip Fractures. Annals of Clinical and Laboratory Science 37:222–232 (2007).
Micronutrients in African-Americans with decompensated and compensated heart failure. Transl Res. 2006 Dec;148(6):301–8.
Hypothesis: Correction of low vitamin D status among Arab women will prevent heart failure and improve cardiac function in established heart failure. Eur J Heart Fail. 2006 Nov;8(7):694–6.
Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf). 2006 Nov;65(5):593–597.
Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65–79. Review.
Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006 Sep;92(1):39–48. Review.
Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):640–6.
Vitamin D metabolism in peripheral blood mononuclear cells is influenced by chewing "betel nut" (Areca catechu) and vitamin D status. J Clin Endocrinol Metab. 2006 Jul;91(7):2612–7.
Osteoporotic fractures and vitamin D deficiency. Aust Fam Physician. 2006 Jul;35(7):519–20, 522.
Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther. 2006 Jul;318(1):90–8.
Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis. 2006 May;186(1):20–8.
Vitamin D and African Americans. J Nutr. 2006 Apr;136(4):1126–9.
Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev. 2006 Mar;11(1):25–33.
Cardiovascular disease in chronic kidney failure: the role of VDR activators. Curr Opin Investig Drugs. 2006 Mar;7(3):206–13. Review.
Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006 Jan;69(1):33–43. Review.
Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci. 2006 Jan;331(1):30–4.
Kidneys, hearts, hormones and immunomodulators: integrated understandings. Blood Purif. 2006;24(1):46–50. Review.
Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J Biol Chem. 2005 Nov 25;280(47):39394–402.
Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005 Nov;68(5):1973–81. Review.
Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J. 2005 Oct;98(10):1024–7. Review.
The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):307–14. Review.
Vitamin D for health and in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):266–75. Review.
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S–88S. Review.
Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004 Sep 1;338(2):143–56. Review.
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004 Mar;79(3):362–71. Review.
Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003 Jan 1;41(1):105–12.
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol. 2002 Jul;16(7):1524–37.
Seasonal variation in cause-specific mortality: are there high-risk groups? 25-year follow-up of civil servants from the first Whitehall study. Int J Epidemiol. 2001 Oct;30(5):1109–16.
Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol. 2001;17(6):567–71.
Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol. 1998 May;31(6):1226–33.
Absence of a seasonal variation in myocardial infarction onset in a region without temperature extremes. Cardiology. 1998 May;89(4):277–82.
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 1997 Sep;103(3):197–207.
Seasonal pattern of acute myocardial infarction in the National Registry of Myocardial Infarction. J Am Coll Cardiol. 1996 Dec;28(7):1684–8.
Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995 Sep;8(9):894–901.
Serum 25-hydroxyvitamin D3 is related to physical activity and ethnicity but not obesity in a multicultural workforce. Aust N Z J Med. 1995 Jun;25(3):218–23.
Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol. 1992 Sep;2(5):697–703.
Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990 Sep;19(3):559–63.
Changes in plasma vitamin levels in the first 48 hours after onset of acute myocardial infarction. Am J Cardiol. 1989 Nov 1;64(16):971–4.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.